scholarly journals Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes

Author(s):  
Seung-Hwan Lee ◽  
Kyungdo Han ◽  
Hyuk-Sang Kwon ◽  
Mee Kyoung Kim
2005 ◽  
Vol 142 (10) ◽  
pp. 813 ◽  
Author(s):  
Alka M. Kanaya ◽  
David Herrington ◽  
Eric Vittinghoff ◽  
Feng Lin ◽  
Vera Bittner ◽  
...  

2018 ◽  
Vol 72 (11) ◽  
pp. 1052-1058 ◽  
Author(s):  
Yang Zhao ◽  
Yu Liu ◽  
Haohang Sun ◽  
Xizhuo Sun ◽  
Zhaoxia Yin ◽  
...  

BackgroundPrevious evidence of an association between body mass index (BMI) and mortality in patients with diabetes was inconsistent. The BMI–mortality association with normal fasting glucose (NFG), impaired fasting glucose (IFG) and prevalent diabetes is still unclear in the Chinese population.MethodsWe analysed data for 17 252 adults from the Rural Chinese Cohort Study during 2007–2008 and followed for mortality during 2013–2014. Participants were classified with NFG, IFG and diabetes according to baseline measurement values of fasting glucose and self-reported diabetes. Multivariable Cox proportional hazard models were used to calculate HRs and 95% CIs across BMI categories by glycemic status.ResultsDuring the 6-year follow-up, 1109 participants died (563/10 181 with NFG, 349/5572 with IFG and 197/1499 with diabetes). The BMI–mortality association was curvilinear, with low BMI (even in normal range) associated with increased mortality regardless of glycemic status. In adjusted Cox models, risk of mortality showed a decreasing trend with BMI≤18 kg/m2, 18<BMI≤20 kg/m2 and 20<BMI≤22 kg/m2 vs 22<BMI≤24 kg/m2: HR 2.83 (95% CI 1.78 to 4.51), 2.05 (1.46 to 2.87) and 1.45 (1.10 to 1.90), respectively, for NFG; 2.53 (1.25 to 5.14), 1.36 (0.86 to 2.14) and 1.09 (0.76 to 1.57), respectively, for IFG; and 4.03 (1.42 to 11.50), 2.00 (1.05 to 3.80) and 1.52 (0.88 to 2.60), respectively, for diabetes. The risk of mortality was lower for patients with diabetes who were overweight or obese versus normal weight.ConclusionsLow BMI was associated with increased mortality regardless of glycemic status. Future studies are needed to explain the ‘obesity paradox’ in patients with diabetes.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1535-P ◽  
Author(s):  
HYE-IN JUNG ◽  
JAEHYUN BAE ◽  
EUGENE HAN ◽  
GYURI KIM ◽  
JI-YEON LEE ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1476-P
Author(s):  
AOIFE M. EGAN ◽  
CHRISTINA WOOD-WENTZ ◽  
KENT R. BAILEY ◽  
ADRIAN VELLA

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1612-P
Author(s):  
IZUMI SHIBATA ◽  
KYOKO K. SATO ◽  
MIKIKO SHIBATA ◽  
HIDEO KOH ◽  
SHINICHIRO UEHARA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document